[1]
2025. Cabozantinib-Exposed Renal Cell Carcinoma Organoids Suggest Transcriptomic Associations with Treatment Resistance in Clear Cell and Nonclear Cell Tumors. Journal of Kidney Cancer. 12, 2 (May 2025), 37–45. DOI:https://doi.org/10.15586/jkcvhl.v12i2.386.